When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Toast (TOST) .Toast currently has an average brokerage recommendation (ABR) of 1.79, on a scale ...

Core Viewpoint - Cimpress (CMPR) shares have recently declined by 5.3% over the past week, but the formation of a hammer chart pattern suggests potential support and a possible trend reversal in the future [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottoming out, with selling pressure likely subsiding, which supports a bullish outlook for the stock [2][5]. - A hammer pattern typically forms during a downtrend, where the stock opens lower, makes a new low, but then closes near or above the opening price, indicating buying interest [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength depends on its placement on the chart [6]. Fundamental Analysis - There has been a recent upward trend in earnings estimate revisions for Cimpress, which is a bullish indicator suggesting potential price appreciation [7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 1%, indicating that analysts expect better earnings than previously predicted [8]. - Cimpress currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].

Core Insights - Upstart Holdings, Inc. (UPST) closed at $48.22, reflecting a -1.4% change from the previous day, underperforming the S&P 500 which gained 0.32% [1] - Over the past month, UPST shares have appreciated by 17.08%, significantly outperforming the Finance sector's gain of 5.94% and the S&P 500's gain of 4.7% [1] Earnings Performance - Upstart Holdings is expected to report an EPS of $0.47, representing an 80.77% increase from the same quarter last year [2] - The consensus estimate for revenue is projected at $288.47 million, indicating a 31.74% rise from the equivalent quarter last year [2] Full-Year Estimates - Zacks Consensus Estimates forecast earnings of $1.68 per share and revenue of $1.04 billion for the full year, reflecting year-over-year changes of +940% and +62.77%, respectively [3] Analyst Estimates - Changes in analyst estimates for Upstart Holdings are crucial as they often reflect shifts in short-term business dynamics, with positive adjustments indicating a favorable outlook on business health and profitability [4] Zacks Rank - Upstart Holdings currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate remaining unchanged over the past month [6] - The Zacks Rank system has shown that 1 ranked stocks yield an average annual return of +25% since 1988 [6] Valuation Metrics - Upstart Holdings has a Forward P/E ratio of 29.2, which is a premium compared to its industry's Forward P/E of 12.31 [7] - The Financial - Miscellaneous Services industry, part of the Finance sector, holds a Zacks Industry Rank of 100, placing it in the top 41% of over 250 industries [7]

Core Insights - CVS Health's stock closed at $79.12, reflecting a +1.38% increase from the previous day, outperforming the S&P 500's gain of 0.32% [1] - Over the past month, CVS shares have decreased by 0.55%, underperforming the Medical sector's increase of 1.67% and the S&P 500's increase of 4.7% [1] Financial Performance - CVS Health is expected to report earnings of $0.99 per share, indicating a year-over-year decline of 16.81%, with projected quarterly revenue of $103.03 billion, up 5.44% from the previous year [2] - For the full year, analysts anticipate earnings of $6.65 per share and revenue of $399.4 billion, representing increases of +22.69% and +7.13% respectively from last year [3] Analyst Estimates - Recent modifications to analyst estimates for CVS Health reflect evolving short-term business trends, with positive changes indicating a favorable outlook on business health and profitability [4] - The Zacks Rank system, which incorporates estimate changes, currently ranks CVS Health at 3 (Hold), with a 0.48% increase in the consensus EPS estimate over the last 30 days [6] Valuation Metrics - CVS Health is trading at a Forward P/E ratio of 11.73, which is below the industry average Forward P/E of 15.51 [7] - The company has a PEG ratio of 0.77, compared to the Medical Services industry's average PEG ratio of 1.71, indicating a more favorable valuation relative to expected earnings growth [7] Industry Context - The Medical Services industry, which includes CVS Health, has a Zacks Industry Rank of 153, placing it in the bottom 39% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the competitive landscape within the industry [8]

Company Performance - Merck (MRK) closed at $106.45, reflecting a +1.34% change from the previous day, outperforming the S&P 500's gain of 0.32% [1] - The stock has decreased by 0.59% over the past month, underperforming the Medical sector's increase of 1.67% and the S&P 500's rise of 4.7% [1] Upcoming Earnings - Merck's upcoming EPS is projected at $2.08, indicating a 20.93% increase compared to the same quarter last year [2] - Revenue is expected to reach $16.18 billion, representing a 3.56% increase from the year-ago quarter [2] Full Year Projections - For the full year, earnings are projected at $8.98 per share and revenue at $64.81 billion, reflecting increases of +17.39% and +1% respectively from the prior year [3] - Recent analyst estimate revisions suggest positive sentiment towards Merck's business operations and profit generation capabilities [3] Valuation Metrics - Merck's Forward P/E ratio stands at 11.7, which is below the industry average of 14.45, indicating a discount relative to its peers [6] - The company has a PEG ratio of 1, compared to the Large Cap Pharmaceuticals industry's average PEG ratio of 1.64 [7] Industry Context - The Large Cap Pharmaceuticals industry, part of the Medical sector, has a Zacks Industry Rank of 161, placing it in the bottom 35% of over 250 industries [8] - The Zacks Industry Rank measures the strength of industry groups based on the average Zacks Rank of individual stocks, with higher-ranked industries outperforming lower-ranked ones [8]

In the latest trading session, Comcast (CMCSA) closed at $29.78, marking a +1.36% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.32%. Meanwhile, the Dow experienced a rise of 0.6%, and the technology-dominated Nasdaq saw an increase of 0.22%. Coming into today, shares of the cable provider had gained 10.12% in the past month. In that same time, the Consumer Discretionary sector gained 3.01%, while the S&P 500 gained 4.7%. The investment community will be p ...

Core Viewpoint - Investors in the Building Products - Home Builders sector should consider Tri Pointe Homes (TPH) as a more favorable option compared to Smith Douglas Homes Corp. (SDHC) for undervalued stock opportunities [1] Valuation Metrics - TPH has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook compared to SDHC, which has a Zacks Rank of 5 (Strong Sell) [3] - TPH's forward P/E ratio is 11.35, significantly lower than SDHC's forward P/E of 19.85, suggesting TPH is undervalued [5] - TPH's PEG ratio is 0.87, while SDHC's PEG ratio is 13.69, further indicating TPH's better valuation in terms of expected earnings growth [5] - TPH has a P/B ratio of 0.83, compared to SDHC's P/B of 2.18, reinforcing TPH's position as a more attractive investment based on market value versus book value [6] - TPH has earned a Value grade of A, while SDHC has a Value grade of F, highlighting the significant difference in their valuation metrics [6] Earnings Outlook - TPH is currently experiencing an improving earnings outlook, which enhances its attractiveness as a value investment [7]

Company Overview - Antero Resources Corporation is an independent explorer engaged in the acquisition and development of natural gas, natural gas liquids, and oil resources in the Appalachian Basin, primarily focusing on unconventional reservoirs [11] - The company holds approximately 542,000 net acres of oil and gas properties in West Virginia and Ohio, making it one of the fast-growing natural gas producers in the United States [11] Investment Ratings - Antero Resources is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of B, indicating a moderate investment outlook [12] - The company has a Momentum Style Score of B, and its shares have increased by 2.2% over the past four weeks [12] Earnings Estimates - In the last 60 days, three analysts have revised their earnings estimates higher for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.05 to $2.00 per share [12] - Antero Resources has an average earnings surprise of +3.7%, suggesting a positive trend in earnings performance [12] Investment Consideration - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Antero Resources is recommended to be on investors' short list for potential investment opportunities [13]

分组1 - Zacks Premium offers various tools for investors, including daily updates, access to Zacks Rank and Industry Rank, and Premium stock screens to enhance investment confidence [1][2] - The Zacks Style Scores categorize stocks based on value, growth, and momentum characteristics, assigning ratings from A to F, with A indicating the highest potential for market outperformance [2][3] 分组2 - The Value Score focuses on identifying undervalued stocks using financial ratios like P/E, PEG, and Price/Sales to highlight attractive investment opportunities [3] - The Growth Score assesses a company's financial health and future outlook by analyzing projected and historical earnings, sales, and cash flow to find sustainable growth stocks [4] - The Momentum Score helps investors capitalize on price trends by evaluating short-term price changes and earnings estimate revisions [5] 分组3 - The VGM Score combines Value, Growth, and Momentum Scores, serving as a comprehensive indicator for stock selection alongside the Zacks Rank [6] - The Zacks Rank model, based on earnings estimate revisions, has shown significant success, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, outperforming the S&P 500 [8] 分组4 - CNX Resources Corporation, an independent oil and gas exploration and production company, is currently rated 3 (Hold) on the Zacks Rank with a VGM Score of B [12] - CNX has a Momentum Style Score of A, with shares increasing by 0.8% over the past four weeks, and has seen positive earnings estimate revisions for fiscal 2025 [13] - The Zacks Consensus Estimate for CNX has risen by $0.08 to $2.18 per share, with an average earnings surprise of +34.5%, making it a noteworthy stock for investors [13]

分组1 - Zacks Premium offers various tools for investors to enhance their stock market confidence and knowledge, including daily updates, research reports, and stock screens [1] - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market within a 30-day timeframe, rated from A to F based on value, growth, and momentum characteristics [2][6] 分组2 - The Value Score identifies attractive and discounted stocks using financial ratios such as P/E and Price/Sales, appealing to value investors [3] - The Growth Score focuses on a company's future prospects by analyzing projected and historical earnings, sales, and cash flow, catering to growth investors [4] - The Momentum Score assists investors in capitalizing on price trends by evaluating recent price changes and earnings estimate revisions [5] 分组3 - The VGM Score combines all three Style Scores, providing a comprehensive indicator for investors who utilize multiple investment strategies [6] - The Zacks Rank, a proprietary stock-rating model, relies on earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, significantly outperforming the S&P 500 [7][8] 分组4 - To maximize returns, investors should target stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B, while also considering stocks with a 3 rank if they possess high Style Scores [9] - The direction of earnings estimate revisions is crucial when selecting stocks, as a stock with a low rank but high Style Scores may still face downward price pressure [10] 分组5 - Wolverine World Wide, Inc. specializes in designing, manufacturing, and distributing a variety of footwear and apparel, recognized for brands like Merrell and Hush Puppies [11] - Currently, Wolverine World Wide holds a 3 (Hold) Zacks Rank with a VGM Score of A, and a Momentum Style Score of A, having seen a 9.1% increase in shares over the past four weeks [12] - With positive earnings estimate revisions and a strong earnings surprise average of +31.8%, Wolverine World Wide is positioned as a noteworthy investment opportunity [12][13]